OpGen Reports First Quarter 2019 Financial Results and Provides Business Update
OpGen Completes Initial FDA 510(k) Submission for its Acuitas® AMR Gene Panel Test to Identify Presence of Antibiotic Resistance
OpGen Announces Date of First Quarter 2019 Financial Results Conference Call
OpGen Announces Closing of Public Offering of Common Stock
Rapid Antibiotic Resistance Surveillance
CONNECT WITH OpGen
We want to add you to our list and stay connected.
Please sign up for email alerts to receive the latest OpGen news.
Microbial Whole Genome Sequencing
Now Available On Demand
Esther Babady, Ph.D
Director of Clinical Microbiology Operations, Memorial Sloan Kettering Cancer Center
This webinar will review current options for rapid pathogen identification from positive blood cultures and discuss the speaker’s experience with the use of AdvanDx QuickFISH® BC kits and their impact on the laboratory workflow and patient outcomes.
Rapid Pathogen Identification